WO2007146359A3 - Sea lice antigen vaccines - Google Patents
Sea lice antigen vaccines Download PDFInfo
- Publication number
- WO2007146359A3 WO2007146359A3 PCT/US2007/013922 US2007013922W WO2007146359A3 WO 2007146359 A3 WO2007146359 A3 WO 2007146359A3 US 2007013922 W US2007013922 W US 2007013922W WO 2007146359 A3 WO2007146359 A3 WO 2007146359A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sea lice
- antigen vaccines
- antigen
- promiscuous
- immune responses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to compositions for inducing immune responses, including an antigen and a promiscuous T-cell epitope. Also provided are methods of inducing immune responses in hosts, comprising administering compositions comprising antigens and promiscuous T-cell epitopes to the host.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80469706P | 2006-06-14 | 2006-06-14 | |
US60/804,697 | 2006-06-14 | ||
US82024606P | 2006-07-25 | 2006-07-25 | |
US60/820,246 | 2006-07-25 | ||
US91107207P | 2007-04-10 | 2007-04-10 | |
US60/911,072 | 2007-04-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007146359A2 WO2007146359A2 (en) | 2007-12-21 |
WO2007146359A3 true WO2007146359A3 (en) | 2008-12-11 |
Family
ID=38832528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/013922 WO2007146359A2 (en) | 2006-06-14 | 2007-06-13 | Sea lice antigen vaccines |
Country Status (2)
Country | Link |
---|---|
CL (1) | CL2007001736A1 (en) |
WO (1) | WO2007146359A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10736941B2 (en) * | 2015-05-19 | 2020-08-11 | National University Corporation Kumamoto University | Cell membrane-permeating peptide |
NO345611B1 (en) * | 2016-01-22 | 2021-05-10 | Norifish As | IgY antibody composition, and use of the composition for reduction of infestation and infection by a Caligidae |
WO2019145730A1 (en) * | 2018-01-25 | 2019-08-01 | Benchmark Animal Health Limited | Sea lice antigens and vaccines |
CN111116727B (en) * | 2020-01-14 | 2021-08-10 | 中国农业大学 | Eimeria tenella rod-shaped body protein 41 and preparation method and application thereof |
CN111514284A (en) * | 2020-04-27 | 2020-08-11 | 中国农业大学 | Chicken coccidiosis multivalent recombinant protein vaccine and preparation method and application thereof |
CN111925449B (en) * | 2020-08-21 | 2022-02-01 | 浙江鼎持生物制品有限公司 | Recombinant CHO cell strain expressing chicken VP2 and chicken GAL-1 fusion protein and construction method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006010265A1 (en) * | 2004-07-28 | 2006-02-02 | National Research Council Of Canada | Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
-
2007
- 2007-06-13 CL CL200701736A patent/CL2007001736A1/en unknown
- 2007-06-13 WO PCT/US2007/013922 patent/WO2007146359A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006010265A1 (en) * | 2004-07-28 | 2006-02-02 | National Research Council Of Canada | Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2007146359A2 (en) | 2007-12-21 |
CL2007001736A1 (en) | 2008-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006041933A3 (en) | Improved vaccines | |
WO2007092792A3 (en) | Yeast-based vaccine for inducing an immune response | |
WO2007120673A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
WO2009039229A3 (en) | Method of conferring a protective immune response to norovirus | |
WO2006126981A3 (en) | Compositions and methods for mucosal vaccination | |
WO2006113214A3 (en) | Vaccine against pandemic strains of influenza viruses | |
MX2013004159A (en) | Norovirus capsid and rotavirus vp6 protein for use as combined vaccine. | |
WO2016176624A3 (en) | Porcine pestvirus, vaccines, and assays | |
WO2006071983A3 (en) | Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines | |
WO2007103048A3 (en) | Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity | |
WO2007024941A3 (en) | Polyvalent vaccine | |
WO2007130493A3 (en) | Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity | |
WO2011032161A8 (en) | Vaccines directed to langerhans cells | |
WO2012116225A3 (en) | Muc1 based glycolipopeptide vaccine with adjuvant | |
WO2009143457A3 (en) | Vaccine composition containing synthetic adjuvant | |
WO2008148057A3 (en) | Cationic lipids compositions and methods for enhancing immune responses to vaccines | |
WO2011156751A3 (en) | Immunogenic vaccine | |
WO2005105139A3 (en) | Mage-3 and ny-eso-1 based polyvalent vaccine for cancer immunotherapy | |
WO2007146359A3 (en) | Sea lice antigen vaccines | |
WO2013054199A3 (en) | Cmv antigens and uses thereof | |
WO2011106607A3 (en) | Subunit vaccines for herpes viruses and methods of use | |
ZA200902443B (en) | Alphavirus replicon particles matched to protein antigens as immunological adjuvants | |
MX340796B (en) | Respiratory syncytial virus antigenic compositions and methods. | |
WO2007144647A3 (en) | Adjuvant compositions | |
WO2010132561A8 (en) | New human rotavirus strains and vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07809539 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07809539 Country of ref document: EP Kind code of ref document: A2 |